Randomised study: effects of the 5‐HT(4) receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis

BACKGROUND: Gastroparesis is defined by delayed gastric emptying with associated symptoms in the absence of mechanical obstruction. AIM: To evaluate pharmacokinetics and pharmacodynamics of felcisetrag, a highly selective 5‐HT(4) receptor agonist, on total gut transit in patients with documented del...

Descripción completa

Detalles Bibliográficos
Autores principales: Chedid, Victor, Brandler, Justin, Arndt, Kayla, Vijayvargiya, Priya, Wang, Xiao Jing, Burton, Duane, Harmsen, W. Scott, Siegelman, Jenifer, Chen, Chunlin, Chen, Yinzhong, Almansa, Cristina, Dukes, George, Camilleri, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Randomised Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251541/
https://www.ncbi.nlm.nih.gov/pubmed/33711180
http://dx.doi.org/10.1111/apt.16304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251541/
https://www.ncbi.nlm.nih.gov/pubmed/33711180
http://dx.doi.org/10.1111/apt.16304

Ejemplares similares